Goxalapladib

CAS No. 412950-27-7

Goxalapladib( —— )

Catalog No. M35993 CAS No. 412950-27-7

Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Goxalapladib
  • Note
    Research use only, not for human use.
  • Brief Description
    Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
  • Description
    Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    412950-27-7
  • Formula Weight
    718.75
  • Molecular Formula
    C40H39F5N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(N(CC1=CC=C(C=C1)C2=CC=C(C(F)(F)F)C=C2)C3CCN(CCOC)CC3)=O)N4C=5C(C(=O)C=C4CCC6=C(F)C(F)=CC=C6)=CC=CN5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • YM 511

    aromatase (CYP19) inhibitor.

  • Ethyl 6-hydroxyhexan...

    Ethyl 6-hydroxyhexanoate can be used to synthesize 2-Bu suberic acid.

  • Nirmatrelvir

    PF-07321332 is a potent and orally active inhibitor of SARS-CoV 3C-like protease (3CLPRO) .